Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility.
暂无分享,去创建一个
D. Watkins-Chow | R. Lloyd | S. Camper | M. Brinkmeier | R V Lloyd | L. J. Cushman | L. Raetzman | A. L. Radak | S A Camper | M L Brinkmeier | L J Cushman | D E Watkins-Chow | L T Raetzman | A L Radak | L. Cushman
[1] D. Watkins-Chow,et al. How many homeobox genes does it take to make a pituitary gland? , 1998, Trends in genetics : TIG.
[2] K. Kovacs,et al. Pituitary gonadotroph adenomas in old Sprague-Dawley rats. , 1985, Journal of submicroscopic cytology.
[3] P. Gruss,et al. Pax-2 controls multiple steps of urogenital development. , 1995, Development.
[4] G. Steinberg,et al. Symptomatic Rathke's cleft cysts. Report of two cases. , 1982, Journal of Neurosurgery.
[5] A. Shimatsu,et al. Functional significance of prop-1 gene expression in pituitary adenomas. , 2000, Endocrine journal.
[6] S. Asa. The pathology of pituitary tumors. , 1999, Endocrinology and metabolism clinics of North America.
[7] D. Herbert,et al. Intercellular communication within the rat anterior pituitary gland: V. Changes in cell‐to‐cell communications as a function of the timing of castration in male rats , 1993, The Anatomical record.
[8] C. Readhead,et al. Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function. A model for human pituitary Rathke's cysts. , 1997, The Journal of clinical investigation.
[9] V. Radhakrishnan,et al. Symptomatic rathke's cleft cysts. , 1983, Surgical neurology.
[10] D. Cooper,et al. The molecular genetics of growth hormone deficiency , 1998, Human Genetics.
[11] M. Low,et al. Simian virus 40 T antigen-induced gonadotroph adenomas: a model of human null cell adenomas. , 1998, Endocrinology.
[12] E. Olson,et al. Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity. , 1997, Trends in genetics : TIG.
[13] S. Schneider-Maunoury,et al. Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. , 1998, Molecular endocrinology.
[14] J. Cogan,et al. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. , 2000, The Journal of clinical endocrinology and metabolism.
[15] S. Yamashita,et al. MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. , 2000, AJR. American journal of roentgenology.
[16] P. Macchia,et al. Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH. , 1998, Development.
[17] A. Bartke. The response of two types of dwarf mice to growth hormone, thyrotropin, and thyroxine. , 1965, General and comparative endocrinology.
[18] R. Odicasandulache. The mouse Pax2 1Neu mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney , 1996 .
[19] M. Helfand,et al. Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. , 1998, Annals of internal medicine.
[20] D. G. Green,et al. Kidney and retinal defects (Krd), a transgene-induced mutation with a deletion of mouse chromosome 19 that includes the Pax2 locus. , 1994, Genomics.
[21] J. Cogan,et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. , 1998, The Journal of clinical endocrinology and metabolism.
[22] M. Busslinger,et al. Pax2 and homeodomain proteins cooperatively regulate a 435 bp enhancer of the mouse Pax5 gene at the midbrain-hindbrain boundary. , 2000, Development.
[23] J. Jameson,et al. Inherited disorders of the gonadotropin hormones , 1996, Molecular and Cellular Endocrinology.
[24] J. Windle,et al. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. , 1990, Molecular endocrinology.
[25] R. Wood,et al. Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice. , 1995, Genes & development.
[26] C. Flück,et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C). , 1998, The Journal of clinical endocrinology and metabolism.
[27] R. Lloyd,et al. Remodeling of hyperplastic pituitaries in hypothyroid α-subunit knockout mice after thyroxine and 17β-estradiol treatment: Role of apoptosis , 1998, Endocrine pathology.
[28] Larry W. Swanson,et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1 , 1990, Nature.
[29] D. Watkins-Chow,et al. Thyroid Hormone Is Essential for Pituitary Somatotropes and Lactotropes * , 1999 .
[30] G. Fink,et al. The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse. , 1983, Endocrinology.
[31] G. Dressler,et al. The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. , 1996, The Journal of clinical investigation.
[32] S. Melmed,et al. Genetic basis of endocrine disease: pituitary tumor pathogenesis. , 1997, The Journal of clinical endocrinology and metabolism.
[33] T. Wagner,et al. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice. , 1993, Endocrinology.
[34] P Grimes,et al. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Rosenfeld,et al. The Ames dwarf gene is required for Pit-1 gene activation. , 1995, Developmental biology.
[36] W. Dobyns,et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux , 1995, Nature Genetics.
[37] Kristina J. Liu,et al. Report of two cases , 1995 .
[38] K. Parker,et al. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation , 1994, Cell.
[39] S. Camper,et al. Targeted ablation of cells in the pituitary primordia of transgenic mice. , 1996, Molecular endocrinology.
[40] John A. Phillips,et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency , 1998, Nature Genetics.
[41] B. Hogan,et al. Manipulating the mouse embryo: A laboratory manual , 1986 .
[42] S. Melmed,et al. Pituitary Tumor Pathogenesis1 , 1997 .
[43] M. Rosenfeld,et al. Combinatorial codes in signaling and synergy: lessons from pituitary development. , 1999, Current opinion in genetics & development.
[44] Malcolm J. Low,et al. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[45] T. Minegishi,et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.
[46] K. Risma,et al. Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. , 1997, Endocrinology.
[47] D F Gordon,et al. Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. , 1994, Molecular endocrinology.
[48] S. Nakamura,et al. Prop-1 gene expression in human pituitary tumors. , 1999, The Journal of clinical endocrinology and metabolism.
[49] M. Dattani,et al. The molecular basis for developmental disorders of the pituitary gland in man , 2000, Clinical genetics.
[50] S. Rhodes,et al. Transcriptional Control of the Development and Function of the Hypothalamic-Pituitary Axis , 2002 .
[51] P. Gruss,et al. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. , 2000, Developmental biology.
[52] D. Whyte,et al. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. , 1996, Development.
[53] Dattani Mt,et al. The molecular basis for developmental disorders of the pituitary gland in man. , 2001 .
[54] P. Chambon,et al. Homeobox Genes in Embryogenesis and Pathogenesis , 1997, Pediatric Research.
[55] J. Milbrandt,et al. Luteinizing Hormone Deficiency and Female Infertility in Mice Lacking the Transcription Factor NGFI-A (Egr-1) , 1996, Science.
[56] C. R. Austin,et al. Mechanisms of sex differentiation in animals and man , 1981 .
[57] P. Leder,et al. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Wilkinson,et al. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities , 1993, Nature.
[59] S. Asa,et al. The cytogenesis and pathogenesis of pituitary adenomas. , 1998, Endocrine reviews.
[60] M. Korbonits,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Expression of the Pituitary Transcription Factor Ptx-1, But Not That of the Trans-Activating Factor Prop-1, Is Reduced in Human Corticotroph Ade , 2022 .
[61] T. Wagner,et al. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[62] 이은직. Inherited disorders of the gonadotropin hormones , 2001 .
[63] A. Shimatsu,et al. Characterization of Prophet of Pit-1 gene expression in normal pituitary and pituitary adenomas in humans. , 1999, The Journal of clinical endocrinology and metabolism.
[64] S. Camper,et al. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. , 1996, Molecular endocrinology.
[65] Wei Wu,et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism , 1996, Nature.
[66] C. Freund,et al. Transcription factor genes and the developing eye: a genetic perspective. , 1996, Human molecular genetics.
[67] M. Helfand,et al. Screening for Thyroid Disease: An Update , 1998, Annals of Internal Medicine.
[68] J. Yoshida,et al. Symptomatic Rathke's cleft cyst. Morphological study with light and electron microscopy and tissue culture. , 1977, Journal of neurosurgery.
[69] C. Readhead,et al. Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development. , 1998, Molecular endocrinology.
[70] S. Mackem,et al. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. , 1996, Development.
[71] S. Camper,et al. Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. , 1996, Development.
[72] E. Carbajo-Pérez,et al. CELL PROLIFERATION IN THE ANTERIOR PITUITARY OF MICE DURING GROWTH , 1989 .